LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 105 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $158,000 | +3.3% | 62,869 | +17.3% | 0.01% | +12.5% |
Q2 2021 | $153,000 | +48.5% | 53,609 | +21.8% | 0.01% | +33.3% |
Q1 2021 | $103,000 | +68.9% | 44,013 | +26.6% | 0.01% | +50.0% |
Q4 2020 | $61,000 | -3.2% | 34,771 | -48.5% | 0.00% | +100.0% |
Q3 2020 | $63,000 | -33.0% | 67,532 | -37.6% | 0.00% | 0.0% |
Q2 2020 | $94,000 | -4.1% | 108,280 | -9.0% | 0.00% | -33.3% |
Q1 2020 | $98,000 | -31.0% | 118,935 | -25.4% | 0.00% | +50.0% |
Q4 2019 | $142,000 | – | 159,351 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,935,485 | $39,477,000 | 3.01% |
Raffles Associates | 2,080,536 | $2,351,000 | 2.51% |
Defender Capital, LLC. | 5,184,035 | $5,862,000 | 2.30% |
Prescott General Partners LLC | 1,851,851 | $2,093,000 | 0.16% |
DAFNA Capital Management LLC | 140,000 | $158,000 | 0.04% |
Fort Sheridan Advisors LLC | 83,931 | $95,000 | 0.03% |
Long Focus Capital Management, LLC | 215,000 | $243,000 | 0.02% |
XTX Topco Ltd | 72,807 | $82,000 | 0.02% |
Ergoteles LLC | 490,895 | $555,000 | 0.02% |
Beirne Wealth Consulting Services, LLC | 45,000 | $51,000 | 0.02% |